EverHint – Breakout Standard – Top 15 Signals for Jul 07, 2026
What This Signal Is
Stocks within 3% of 52-week high - standard breakout momentum setups. Stock showing strong momentum near or at highs. Increased volume confirms institutional interest. Breaking out or consolidating near resistance.
Entry Criteria:
- Strong RSI momentum
- Volume surge above average
- Within 3% of 52-week high
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: Medium-High
Market Context
Equity markets are experiencing a modest broad-based pullback, with tech-heavy indices bearing the brunt of the selling pressure as the Nasdaq leads declines at -1.20% versus the more measured -0.25% drop in the Dow Jones. This divergence suggests risk appetite is selectively contracting, with growth-oriented and higher-multiple sectors facing greater headwinds than value-tilted areas. For momentum-swing strategies, this environment creates a mixed backdrop — trending setups may see follow-through disrupted intraday, while mean-reversion opportunities could increase as volatility picks up.
The VIX rising 4.11% to 16.21 signals a meaningful uptick in near-term uncertainty, though the absolute level remains within a historically moderate range. This level of implied volatility is generally sufficient to generate the intraday price swings that momentum-swing strategies depend on, without the chaotic, whipsaw conditions seen above VIX 25-30. Traders should expect slightly wider bid-ask spreads and more pronounced intraday reversals, making entry timing and stop placement more critical than in low-volatility regimes.
Healthcare emerging as the top sector for signals today is notable given the broader risk-off tone. Defensive sector rotation is a common response to market uncertainty, and Healthcare's relative strength aligns with that pattern. Momentum-swing setups in defensive sectors during mild selloffs can offer more stable trend characteristics compared to high-beta alternatives, as institutional capital tends to rotate into these areas rather than exit entirely — providing a cleaner directional bias for swing-oriented entries.
📊 Signals (15 of 20 total)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | CLDX | Celldex Therapeutics, ... | Healthcare | $39.93 | 1.00 | — | $2.7B |
| 2 | PTGX | Protagonist Therapeuti... | Healthcare | $140.85 | 0.93 | -$12,996,420 | $9.1B |
| 3 | ALMS | Alumis Inc. Common Stock | Healthcare | $29.27 | 0.79 | — | $3.6B |
| 4 | L | Loews Corporation | Financial Services | $116.95 | 0.78 | +$523,700 | $24.1B |
| 5 | VRTX | Vertex Pharmaceuticals... | Healthcare | $522.25 | 0.74 | — | $132.5B |
| 6 | MNST | Monster Beverage Corpo... | Consumer Defensive | $96.92 | 0.70 | — | $94.8B |
| 7 | DYN | Dyne Therapeutics, Inc. | Healthcare | $23.83 | 0.68 | -$3,407,094 | $3.9B |
| 8 | RLAY | Relay Therapeutics, Inc. | Healthcare | $19.74 | 0.58 | — | $3.5B |
| 9 | TRVI | Trevi Therapeutics, Inc. | Healthcare | $19.50 | 0.58 | — | $2.8B |
| 10 | TENB | Tenable Holdings, Inc. | Technology | $40.62 | 0.47 | -$225,425 | $4.5B |
| 11 | FTDR | Frontdoor, Inc. | Consumer Cyclical | $78.42 | 0.44 | — | $5.5B |
| 12 | BCRX | BioCryst Pharmaceutica... | Healthcare | $10.99 | 0.27 | -$1,818,506 | $2.3B |
| 13 | LINE | Lineage, Inc. | Real Estate | $44.00 | 0.23 | — | $10.0B |
| 14 | STAG | STAG Industrial, Inc. | Real Estate | $39.12 | 0.23 | — | $7.5B |
| 15 | UMBF | UMB Financial Corporation | Financial Services | $146.00 | 0.22 | — | $11.1B |
Field Notes
Sector concentration: Healthcare (10), Financial Services (2), Consumer Defensive (2)
Insider selling: BCRX (BioCryst Pharmaceuticals, Inc., -$1,818,506), DYN (Dyne Therapeutics, Inc., -$3,407,094), PTGX (Protagonist Therapeutics, Inc., -$12,996,420)
Insider buying: L (Loews Corporation, +$523,700)
Data coverage: 40.0% insider, 0.0% congressional, 0.0% earnings, 20.0% news
Peer Analysis
RLAY (Relay Therapeutics, Inc.): Leads 5 peers: SNDX ($23.24), ORIC ($10.88), AMLX ($18.17), INBX ($100.75), UPB ($7.86)
MNST (Monster Beverage Corporation): Leads 5 peers: CL ($95.03), CCEP ($106.50), MDLZ ($60.22), KDP ($31.49), DEO ($82.84)
L (Loews Corporation): Leads 5 peers: CINF ($189.06), MKL ($1969.34), BAP ($386.47), WRB ($71.54), CFG ($71.78)
TENB (Tenable Holdings, Inc.): Leads 5 peers: DOCN ($137.12), WRD ($5.43), RELY ($24.13), SPSC ($60.93), VRNS ($45.84)
Recent Headlines
BCRX (BioCryst Pharmaceuticals, Inc.)
- BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTGX (Protagonist Therapeutics, Inc.)
- PTGX Stock Surges 64% in Six Months: What Is Driving the Rally?
- Protagonist Therapeutics Reports Granting of Inducement Awards
STAG (STAG Industrial, Inc.)
- STAG Industrial's Revenue Growth And Rising Cash Flow Outshine Underperformance
- 3 Equity REIT Stocks to Watch Amid Rising Demand Trends
- The Dividend Portfolio That Pays More Than The Average Rent In America
- What It Takes To Build A Portfolio That Covers A Retiree’s Grocery Bill Forever
- My 5 Greatest REIT Winners Of All Time
- 3 REITs to Buy for Passive Income in July
- Stag Industrial To Report Second Quarter 2026 Results July 28, 2026
- STAG Industrial: A REIT On An Acquisition Spree Across America, As Leases Grow
- Want $1,500 a Month in Rent Without a Single 2 a.m. Phone Call?
TENB (Tenable Holdings, Inc.)
- Why Tenable Holdings Rallied on Monday
- Tenable Named as the Current Company to Beat for AI-Powered Exposure Assessment in a June 2026 Gartner® Report
- Tenable (TENB) Surges 10.1%: Is This an Indication of Further Gains?
Vlad's Take
Today's signals: Strong sector concentration in Healthcare (10 signals) suggests sector-specific rotation. 1 signal with insider buying adds conviction. 7 signals showing insider selling warrant caution.
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.